Dr. Tyna Moore

Go to vivarays.com and use code DRTINA at checkout.

Anyway, according to the study, people on average regain at a rate of 0.4 kilograms per month after cessation of the weight loss medications leading to a projected return of baseline weight after 1.7 years.

Keep in mind, this was like...

So they looked at all these people in all these studies and there were some that were like on the low end and some that were on the high end and they had to, you know, come up with a mean to report the data.

Although weight loss resulted in improvements in hemoglobin A1C, fasting glucose, total cholesterol, triglycerides, systolic and diastolic blood pressure, all markers returned to baseline within 1.4 years of treatment cessation.

The rate of weight gain after the cessation of the weight loss medications was faster than after the cessation of drugs.

lifestyle, basically.

So they looked at two things here.

There were 37 studies, 63 intervention arms, 9,441 adults with overweight or obesity.

The drugs range from the older agents to the new dual incretins, all the way up to chair's appetite.

Keep in mind, Reta-Trutide is not FDA approved, guys.

If you're getting Reta-Trutide, it's not FDA approved yet.

And you're probably getting it from a research lab.

So I'm not gonna talk on that until we have it.

The average regain, like I said, was 0.4 kilograms per month.

Return to baseline 1.7 years.

For the newer medications, the newer semaglutide and terzapatide, there was a faster regain of 0.8 kilograms per month and a return to baseline in 1.5 years instead of 1.7.

They are stronger and more potent.

They induce a more

severe weight loss.